| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 193.54B | 194.53B | 192.69B | 187.72B | 176.17B | 154.92B |
| Gross Profit | 81.62B | 82.88B | 77.89B | 74.05B | 66.80B | 56.77B |
| EBITDA | 23.93B | 25.43B | 24.20B | 22.44B | 17.35B | 15.25B |
| Net Income | 9.26B | 9.46B | 9.57B | 7.58B | 5.63B | 2.56B |
Balance Sheet | ||||||
| Total Assets | 215.68B | 225.46B | 232.98B | 236.33B | 233.42B | 234.22B |
| Cash, Cash Equivalents and Short-Term Investments | 23.88B | 27.01B | 34.88B | 35.66B | 38.30B | 37.94B |
| Total Debt | 29.71B | 34.96B | 40.66B | 48.22B | 52.70B | 61.97B |
| Total Liabilities | 77.33B | 80.25B | 90.83B | 99.27B | 101.16B | 106.58B |
| Stockholders Equity | 138.05B | 144.90B | 141.84B | 136.76B | 131.97B | 127.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.66B | 11.76B | 6.41B | 12.91B | 9.61B |
| Operating Cash Flow | 0.00 | 17.64B | 21.74B | 17.59B | 17.48B | 17.13B |
| Investing Cash Flow | 0.00 | -10.56B | -8.52B | -10.89B | -3.03B | 886.00M |
| Financing Cash Flow | 0.00 | -14.95B | -13.99B | -9.34B | -14.09B | -10.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.12T | 54.00 | 19.84% | 0.90% | 11.25% | 16.84% | |
73 Outperform | ¥720.16B | 15.94 | 8.48% | 2.02% | 5.20% | 6.54% | |
73 Outperform | ¥70.50B | 11.12 | ― | 2.73% | 9.07% | 42.66% | |
71 Outperform | ¥251.64B | 13.68 | ― | 1.46% | 12.93% | 32.83% | |
69 Neutral | ¥136.51B | 14.34 | ― | 4.49% | 0.96% | -1.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥102.41B | 28.68 | 5.53% | 6.09% | -2.97% | -60.84% |